Fundraising FoxFrontier Path VC — Full Portfolio
8 tracked investments · listed companies and verified rows first
Deeptech startup in San Francisco transforming training and collaboration with its proprietary non-invasive mixed reality device AIR, initially focused on healthcare.
Co-investorsFalconX VenturesIdeaship
Breaking develops engineered microorganisms and enzymes—notably a microbe variant called MICROBE X-32—that biologically degrade many types of plastic waste into organic matter.
BiotechCleantechClimate Tech
Sukanya Punthambaker(Founder)Vaskar Gnyawali(Founder)inGeorge Church(Founder)Donald Ingber(Co-founder)inAlba Tull(Founder)inKent Wakeford(Founder)in
Co-investorsCarnrite VenturesBuilders VC
Cylera provides a healthcare cybersecurity platform focused on connected medical devices, IoT, and IT assets, giving hospitals and health systems visibility, risk assessment, and threat detection across their environments.
CybersecurityHealthtechIoTNew York, US
Timur Ozekcin(Executive Officer, Director)inSean Abraham(Executive Officer, Director)inApostolos Bakoyiannis(Executive Officer)Owen Wilson(Director)
Co-investorsAlumni VenturesContour Venture PartnersDreamit VenturesEpsilon Health InvestorsGreat Oaks Venture CapitalLitquidity Ventures+7 more
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Thomas Kevin Murphy, Ph.D.(Executive Officer)JONATHAN SPORN(Founder)in
Co-investorsAera VCAlumni VenturesAwareness VentureFrontera Technology VenturesJames Beshara FundJLS+25 more
Neatsy.ai uses iPhone-camera AI computer vision for foot scanning and remote orthopedic care and physical therapy.
Digital HealthMenlo Park, US
Artem Semjanowin
Co-investorsOpen Venture CapitalTechstarsCabra VCFlyer One Ventures
neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility.
Deep TechHealthtechMedical DevicesSan Francisco, US
Amit Vohra(Executive Officer, Director)inAbhita Batra(Executive Officer, Director)Shibu Gangadharan(Executive Officer)
BoardKrishna R. Bhupal(Director)Rahul Talwar(Director)
Co-investorsShangBay Capital LLCSonder Capital
Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Matt Angle(Founder and CEO)in
Co-investors15th RockAlpha EdisonAnthropy PartnersATEL VenturesCapital FactoryCloudStone Capital+26 more
Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions.
BiotechHardwareHealthtechMedical DevicesOakland, US
Amit Vohra(Executive Officer, Director)inMichael Bartholomew(Executive Officer, Director)inDinesh Kumar(Executive Officer)in
BoardJonathan Chen(Director)Derek Hennecke(Director)inDushyant Chipalkatty(Director)
Co-investorsAngel Physicians FundBand of AngelsZynext Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.